Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Cash from Financing Activities (2023 - 2026)

Compass Therapeutics' Cash from Financing Activities history spans 4 years, with the latest figure at $3.4 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 512.88% to $3.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $133.8 million, a 14802.09% increase, with the full-year FY2025 number at $129.6 million, up 647.54% from a year prior.
  • Cash from Financing Activities hit $3.4 million in Q1 2026 for Compass Therapeutics, up from $1.1 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CMPX hit a ceiling of $129.4 million in Q3 2025 and a floor of -$815000.0 in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $12.8 million across 4 years, with a median of $31000.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 109.52% in 2024 and later soared 6468150.0% in 2025.
  • Tracing CMPX's Cash from Financing Activities over 4 years: stood at -$158000.0 in 2023, then soared by 40.51% to -$94000.0 in 2024, then skyrocketed by 1230.85% to $1.1 million in 2025, then soared by 216.56% to $3.4 million in 2026.
  • Business Quant data shows Cash from Financing Activities for CMPX at $3.4 million in Q1 2026, $1.1 million in Q4 2025, and $129.4 million in Q3 2025.